Ibuprofen Liquid Capsules 2 x 200 mg Efficacy and PK/PD Study in Surgical Removal of Impacted Third Molars

PHASE3CompletedINTERVENTIONAL
Enrollment

294

Participants

Timeline

Start Date

August 9, 2022

Primary Completion Date

June 15, 2023

Study Completion Date

June 15, 2023

Conditions
Tooth, ImpactedTooth DiseasesStomatognathic Diseases
Interventions
DRUG

Ibuprofen 200Mg Oral Cap

2 x 200mg Liquid Capsules once in 12 hours

DRUG

Ibuprofen 200Mg Oral Tablet

2 x 200mg Tablets once in 12 hours

OTHER

Placebo Liquid Capsule

2 x Liquid Capsules once in 12 hours

OTHER

Placebo Tablets

2 x Tablets once in 12 hours

Trial Locations (1)

84107

JBR Clinical Research, Salt Lake City

Sponsors
All Listed Sponsors
collaborator

Premier Research Group plc

UNKNOWN

lead

Reckitt Benckiser Healthcare (UK) Limited

INDUSTRY